To further investigate the extent of cross talk between FRA1 and the TGFβ pathway, we assessed the expression of several mesenchymal and epithelial FRA1 targets in another KRAS mutant TGFβ-responsive CRC cell line, SW837. This evidence concerns the gene FOSL1 and colorectal carcinoma.